Phone : +91-22-2207 0099 Email : info@ottokemi.com, sales@ottokemi.com
4-(5-Benzol[1,3]dioxol-5-yl-4-pyrldin-2-yl-1H-imidazol-2-yl)-benzamide hydrate, 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]-benzamide hydrate, 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]-benzamide hydrate
S 0619
C22H16N4O3.xH2O
29420090
18%
301836-41-9
384.39
Vial / Bottle
S 0619 (OTTO) SB 431542 hydrate ≥98% (HPLC), powder Cas 301836-41-9 - used to study the correlation of platelet-derived growth factor receptor B expression and TGF-β pathway activation in colorectal tumor cells. S 0619 (OTTO) SB 431542 hydrate ≥98% (HPLC), powder Cas 301836-41-9 - used to study the role of TGF-β signaling in modulation of extracellular matrix and myoblast differentiation.
SB 431542 is a small molecule that acts as a specific and selective inhibitor of TGFβ RI, ACTR-IB and ACTR-IC (transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, 5, and 7).
Cell biology, Bioactive small molecules
≥98%
Powder
DMSO: soluble 10 mg/mL
H2O: insoluble
-20 °C
RIDADR NONH for all modes of transport WGK Germany 3
DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received. For laboratory use only. Not for drug, medical, household, or any other unauthorized application. We assume no liability for misuse or unauthorized application of the product. Please test before use.